Fundraising in Troubled Times: Alternatives to Traditional Forms of Funding

BayBio presents a morning seminar on alternative fundraising strategies for biotech startups. From the event description:

“For life science companies facing lengthy, high-cost R&D cycles, government approvals, and difficult clinical trials, funding is their lifeblood. Of course, there’s less money to go around these days with the IPO market essentially having grinded to a halt and the competition for VC funding fierce. Fortunately, there are other sources.

This panel discussion will cover some of the lesser-known funding options available in today’s marketplace. Accounting, finance, and legal considerations surrounding these alternatives will be discussed in detail. In addition, experts working at venture capital and Super Angel firms, to provide their perspectives and insights.

The following areas will be addressed:

  • Private Investments in Public Securities (PIPEs)
  • Reverse mergers
  • Super Angel funding
  • Smaller venture capital rounds
  • Foreign investor financings
  • Federal government grants

Moderator: Michael Benjamin, Shareholder, Burr Pilger Mayer, Inc.


Larry Gerrans, President & CEO, Sanovas

Jerry Iwata, Vice President, Wells Fargo Bank

Bruce W. Jenett, Partner and Co-Chair, Global Life Sciences Sector DLA Piper

Michael Powell, PhD, General Partner, Sofinnova Ventures

Kim Tsuchimoto, Chief Financial Officer, Treasurer and Secretary Raptor Pharmaceutical Corporation”

Information here, registration here.